Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
Hradec Kralove, Czechia
University hospital in Hradec Králové
Sokolská 581, 500 05 Hradec Králové
About Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Genentech, Inc.
1
Clinical Trials at Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
During the past decade, Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 11 clinical trials were completed, i.e. on
average, 366.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
2011-12-06
2017-10-31
Completed
30
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
According to Clinical.Site data, the most researched conditions in "Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology" are
"Breast Cancer" (7 trials), "Gastric Cancer" (2 trials), "Basal Cell Carcinoma" (1 trials), "Malignant Melanoma" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
Most popular intervention types in "Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Trastuzumab" (5 trials), "Pertuzumab" (4 trials), "Placebo" (4 trials), "Paclitaxel" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
The vast majority of trials in "Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology" are
9 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology
Currently, there are NaN active trials in "Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".